My Cancer is an educational resource for cancer patients and their caregivers, sponsored by Caris Life Sciences®. The site is designed to provide information about molecular profiling, cancer biomarkers and the transformation of cancer treatment through emerging research.
font1
font2
font3
font4
font5
font6
font7
font8
You’re at the beginning of your journey — probably overwhelmed, but optimistic. There’s a lot of information to take in — what is cancer, how is it affecting me, how can I fight it? — and you want to make sure you start on the right path as quickly as possible.
You’re making every effort to get well — maybe feeling a little rundown from treatment, but staying positive. You already know the basics about cancer treatment, but you may wonder if your treatment is going as well as it should, or if there’s anything more you could be doing.
You’ve come a long way down your treatment path, but treatments have either stopped working for you or none have worked yet. But you’re far from ready to give up hope and have started aggressively researching new options.
My Cancer is an educational resource for cancer patients and their caregivers, sponsored by Caris Life Sciences®. The site is designed to provide information about molecular profiling, cancer biomarkers and the transformation of cancer treatment through emerging research.
© 2013 Caris Life Sciences. All rights reserved. Privacy | Link Policy
The information presented on this site is intended to provide cancer patients with information about molecular profiling services and the role these services can play in providing tumor-specific biomarker information and therapy associations to their oncologists to help inform cancer treatment decisions and is not a substitute for physician advice and consultation. Molecular profiling is not for everyone. Only your doctor can decide if the information provided by molecular profiling will be helpful in your particular cancer case.
The patient testimonials featured on this site were selected and developed by Caris Life Sciences®, which provides Molecular Intelligence™ Services, and are not intended to be representative of all patients with cancer. Further, these testimonials and the information on this site should not be considered medical advice. Each patient case is different and results may not be typical. Oncologists should make the final treatment selection for each patient.
American Society of Clinical Oncology (ASCO) and ASCO are registered trademarks of ASCO; National Comprehensive Cancer Network (NCCN) and NCCN are registered trademarks of NCCN. ASCO and NCCN do not endorse any product or therapy.
Caris Molecular Intelligence Services were developed and its performance characteristics were determined by Caris Life Sciences, a medical laboratory CLIA-certified in compliance with the U.S. Clinical Laboratory Amendment Act of 1988 and all relevant U.S. state regulations. Caris Molecular Intelligence Services have not been approved by the United States Food and Drug Administration.
Facebook
